Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Here's something to think about

Those links confirm exactly what I thought. Hence, all of thse applications will expire in 2016, regardless of whether or not they mature into a patent. 20 years from the priority date. At least that is the way I read it. Corrections welcomed.

So, it appears we are back to the orginal question. Why in the heck are we spending time, effort, and $ on these applications. What is the expected benefit?

Opty

Share
New Message
Please login to post a reply